Evidence map›Paper›PMID 23735433›Full record

ArticleStatistical applications in genetics and molecular biology2013

Block-diagonal discriminant analysis and its bias-corrected rules.

Herbert Pang, Tiejun Tong, Michael Ng

Abstract read
In one paragraph

Article in Statistical applications in genetics and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Sparse Linear Discriminant Analysis using the Prior-Knowledge-Guided Block Covariance Matrix.Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Herbert PangDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.
Tiejun Tong
Michael Ng

Funding

Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIDIAN, MARIE, KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
NCI NIH HHS P01 CA142538NCI NIH HHS P01CA142538
6 · The paper itself

Abstract

High-throughput expression profiling allows simultaneous measure of tens of thousands of genes at once. These data have motivated the development of reliable biomarkers for disease subtypes identification and diagnosis. Many methods have been developed in the literature for analyzing these data, such as diagonal discriminant analysis, support vector machines, and k-nearest neighbor methods. The diagonal discriminant methods have been shown to perform well for high-dimensional data with small sample sizes. Despite its popularity, the independence assumption is unlikely to be true in practice. Recently, a gene module based linear discriminant analysis strategy has been proposed by utilizing the correlation among genes in discriminant analysis. However, the approach can be underpowered when the samples of the two classes are unbalanced. In this paper, we propose to correct the biases in the discriminant scores of block-diagonal discriminant analysis. In simulation studies, our proposed method outperforms other approaches in various settings. We also illustrate our proposed discriminant analysis method for analyzing microarray data studies.

Indexed as

AlgorithmsCase-Control StudiesComputer SimulationData Interpretation, StatisticalDiagnosis, DifferentialDiscriminant AnalysisGene Expression ProfilingGene Regulatory NetworksHigh-Throughput Nucleotide SequencingHumansLymphomaModels, BiologicalModels, StatisticalMolecular Diagnostic TechniquesShock, Septic

Identifiers

PMID23735433
PMCPMC3856189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.